Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

IgG N-glycosylation is a potential biomarker for sepsis (CROSBI ID 681467)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija

Keser, Toma ; Pavić, Tamara ; Fressl Juroš, Gordana ; Lauc, Gordan ; Gornik Olga IgG N-glycosylation is a potential biomarker for sepsis. 2019

Podaci o odgovornosti

Keser, Toma ; Pavić, Tamara ; Fressl Juroš, Gordana ; Lauc, Gordan ; Gornik Olga

engleski

IgG N-glycosylation is a potential biomarker for sepsis

Sepsis is defined as infection with organ dysfunction due to a dysregulated immune response. It is a potentially fatal condition and its clinical manifestations vary with a rapid progression. Due to the existence of non- infectious systemic inflammatory response syndrome (SIRS) in many critical patients, how to differentiate sepsis from the non-infectious SIRS at the early stage has become a burning issue. The clinical values of many existing biomarkers are still uncertain or controversial. Therefore, we investigated a potential diagnostic and prognostic value of IgG N-glycosylation in 72 patients who underwent abdominal surgery, of which 36 developed sepsis. The blood samples were taken few hours after the surgery, IgG was isolated, N-glycans released with PNGase F and the labelled purified N-glycans were analysed with HILIC-UHPLC-FLR. The data analysis showed that patients who developed sepsis had a decrease in neutral glycan structures with bisecting N- acetylglucosamine at the time of sampling. Furthermore, patients who developed septic shock had an increase in monosialylated digalactosylated IgG N-glycan and a decrease in general IgG core fucosylation. We also found a strong association between IgG N-glycome and presepsin (sCD14-subtypes), a novel sepsis biomarker. Additionally, we compared the sepsis prediction performance of IgG N-glycome and presepsin, using a regularized logistic regression model. The IgG N-glycome showed a significantly better prediction performance (AUC=0.933) compared to presepsin (AUC=0.738). Altogether, we conclude that IgG N- glycosylation has a great potential to become a novel biomarker for sepsis, although further replication studies with a bigger sample size are required to confirm this.

sepsis ; N-glycans ; IgG ; septic shock ; biomarker

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

SP5

2019.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

Congress of the Croatian Society of Biochemistry and Molecular Biology "Crossroads in Life Sciences" (HDBMB2019)

pozvano predavanje

25.09.2019-28.09.2019

Lovran, Hrvatska

Povezanost rada

Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Farmacija